1[1]Keks N,McGrath J,Lambert T,et al.The Australian multicen tre double-blind comparative study of remoxipride and thioridazine in schizophre nia[J].Acta Psychiatr Scand,1994,90:358-365.
6[6]Potenza MN,Holmes JP,Kanes SJ,McDougle CJ. Olanzapine treatment of c hild ren,adolescents and adults with pervasive developmental disorder:an open-label p ilot study[J].J Clin Psychopharmacol,1999,19:37-44.
7[7]Wirshing DA,Wirshing WC,Kysar L,et al.Novel antipsychotics:compa rison of weight gain liabilities[J].J Clin Psychiatry,1990,60:358-363.
8[8]Peuskens J,Link CG .A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia[J].Acta Psychiatr Scand,1997,96:265-273.
9[9]Kelly DL,Conley RR,Love RC,Horn DS,Ushchak CM..Weight gain in adoles cents treated with risperidone and conventional antipsychotics over six months[ J].J Clin Adolesc Psychopharmacol,1998,8:151-159.
10[10]Loo H,Poirier-Litter MF,Theron M,Rein W,Fleurot O.Amisulpride versus pla cebo in the medium-term treatment of the negative symptoms of schizoprenia[J]. Br J Psychiatry,1997,170:18-22.
7Zhu A J,Walsh B T.Pharmacologic treatment of eating disorders.Can J Psychiat,2002,47 (3):227.
8Malone RP,Cater J,Skeikh R M,et al.Olanzapine versus haloperidol in children with antistic disorder:An open pilot study.J Am Acad Child Adolesc Psychiatry,2001,40:887.
9Friedlander R,Lazar S,Klancnik J.Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.Can J Psychiatry,2001,46:741.
10Brodaty H,Low L F.Aggression in the elderly.J Clin Psychiatry,2003,64(4),36.
